October 17, 2000
AMERIPATH,INC. CONFERENCE CALL TO BE BROADCAST BY INVESTOR BROADCAST
NETWORK OVER THE INTERNET
Riviera Beach, FL, October 17, 2000 – AmeriPath, Inc. (Nasdaq:
PATH), the nation’s leading physician and laboratory company
focused on anatomic pathology, cancer diagnostic, and healthcare
information services, will broadcast its conference call discussing
financial results for the third quarter ended September 30, 2000
on Tuesday, October 24, 2000 at 10:00 a.m. EST over the Internet.
James C. New, Chairman and Chief Executive Officer and Robert
P. Wynn, Executive Vice President and Chief Financial Officer
will host the call.
Consistent with the Company’s desire to make information
accessible to everyone, we are making available the ability for
every interested investor to listen to the live call and have
access to this information simultaneously.
This event is available through Investor Broadcast Network’s
Vcall website, located at http://www.vcall.com. Listeners should
go to the website at least fifteen minutes before the event to
register, download, and install any necessary audio software.
For those unable to attend the live broadcast, a replay will
be available beginning approximately one hour after the event.
There is no charge to access the event.
A telephonic playback of the call will be available from 12:00
p.m., October 24 to 12:00 p.m., October 25. The PostView dial-in
number is 800-633-8284 or 858-812-6440, reservation #16603282.
AmeriPath, Inc. is the nation’s largest physician and
laboratory company focused on providing anatomic pathology cancer,
diagnostic, and healthcare information services to physicians,
hospitals, national clinical laboratories and managed care organizations.
The company presently operates in 14 states and employs 307 physicians
that provide medical services through outpatient pathology laboratories,
hospital inpatient laboratories and outpatient surgery centers.
...............................................................................................................................
The statements
of James C. New and other statements contained in this
press release are “forward-looking statements” which
are based on management’s current beliefs and expectations.
Past performance is not necessarily indicative of future results.
In addition, forward-looking statements – which are identified
by words such as “may”, “should”, “believe,” “expect,” “anticipate” and
similar expressions -- are subject to a number of risks and uncertainties
which could cause actual results to differ materially from historical
results or those expected or anticipated. These include risks
and uncertainties relating to demand for pathology services,
pricing, federal and state regulation (and compliance), reimbursement
rates, government and third party payments, dependence upon pathologists
and contracts, completion and integration of acquisitions and
affiliations, competitive factors and technology. Further information
regarding risks, uncertainties and other factors that could affect
the Company’s financial results, or could cause actual
results to differ materially from those expected or anticipated,
are included in the Company’s Form 10-K for the year ended
December 31, 1999 and subsequent filings with the SEC.
